Page 22 - NIH Bulletin Vol. 16 December 2020
P. 22

Bulletin National Institutes of Health, Malaysia  Vol 16 • 2020










          The table below summarises some of the above-mentioned studies related to COVID-19 conducted by ICR or its Clinical
          Research Centre (CRC) Network, with relevant collaborators.


                                                       Clinical Trials

                                                   Institute/Hospital
           No.             Study Title               and Principal       Study Background and Progress (As of
                                                                                      27/7/2020)
                                                    Investigator (PI)

           1    An international randomised trial of   Hospital Pulau   Provide reliable estimates on any effects of
                additional treatments for COVID-19   Pinang & eight other   Remdesivir, Hydroxychloroquine, Lopinavir
                in hospitalised patients who are all   MOH hospitals  with Ritonavir and Lopinavir with Ritonavir
                receiving the local standard of care.                 and Interferon in hospital mortality of severe
                (WHO Solidarity Trial)           PI: Dr Chow Ting Soo  COVID-19. Collaboration study with WHO.

                (NMRR-20-686-54503)                                   Progress:
                                                                      Recruitment started 21/4/2020.


           2    An open-label, randomised, adaptive   Institute for Clinical   To compare the efficacy of Methylprednisolone
                cross-over interventional study to   Research and CRC   versus Tocilizumab in improving clinical
                evaluate the efficacy and safety of   Networks (Hospital   outcomes and reducing the need for ventilator
                Tocilizumab versus corticosteroid in   Sungai Buloh,   support in COVID-19 patients with moderate
                hospitalised COVID-19 patients with   Hospital Kuala   COVID-19 disease at risk for complications of
                high risk of progression.        Lumpur, Hospital     cytokine storm. Collaboration between ICR,
                                                 Tuanku Jaafar)       Hospital Sungai Buloh, Hospital Kuala Lumpur,
                (NMRR-20-735-54656)                                   Hospital Tuanku Ja’afar and University Malaya.
                                                 PI: Dr. Suresh Kumar
                                                 Chidambaram          Progress:
                                                                      Data collection



                                                   Clinical Epidemiology


                                                   Institute/Hospital
           No.             Study Title               and Principal       Study Background and Progress (As of
                                                                                      27/7/2020)
                                                    Investigator (PI)

           1    COVID-19: Four paediatric cases in   Hospital Sungai   Brief report of four Paediatric cases of COVID-19
                Malaysia. (Short Communication)  Buloh                infection in Malaysia ranging from 20 months
                                                                      to 11 years old that contracted virus from China.
                                                 PI: Dr See Kwee      Collaboration between CRC Hospital Sungai
                                                 Ching                Buloh, ICR and DDG (P&ST).

                                                                      Progress:
                                                                      Published in International Journal of Infectious
                                                                      Diseases. (doi: 10.1016/j.ijid.2020.03.049)










       22
   17   18   19   20   21   22   23   24   25   26   27